2016-11-14T16:58:04-06:00 2016-06-30 954611603 HENSIEK & CARON CPA'S 650 SIERRA MADRE VILLA 303 PASADENA CA 91107 990 2015-07-01 770009065 DR SUSAN LOVE RESEARCH FOUNDATION DRSU 3108280060 16133 VENTURA BLVD NO 1000 ENCINO CA 91436 STEPHEN GINNEGAR CFO 3108280060 2016-11-14 1 BARRY B HENSIEK P00163798 6267929988 2015 2017-02-10 21:41:12Z SUSAN LOVE 16133 VENTURA BLVD NO 1000 ENCINO CA 91436 3445483 0 X WWW.DRSUSANLOVERESEARCH.ORG X 1983 CA ERADICATING BREAST CANCER THROUGH INNOVATIVE & COLLABORATIVE RESEARCH ON CAUSE & PREVENTION. 8 7 17 380000 0 0 1928706 2967182 15000 51500 180209 -138818 -29750 -29501 2094165 2850363 70000 0 0 0 1209446 1376777 0 0 273590 1696366 1386617 2975812 2763394 -881647 86969 3102058 3310349 211272 346642 2890786 2963707 X THE MISSION OF THE DR. SUSAN LOVE RESEARCH FOUNDATION IS TO ACHIEVE A FUTURE WITHOUT BREAST CANCER BY ENGAGING THE PUBLIC AND SCIENTIFIC COMMUNITIES IN INNOVATIVE RESEARCH. 0 0 2063209 51510 RESEARCHDR. SUSAN LOVE RESEARCH FOUNDATION CONDUCTS AND COLLABORATES ON STATE OF THE ART RESEARCH WITHIN THE SCIENTIFIC COMMUNITY, SETTING THE STAGE FOR FUTURE MEDICAL BREAKTHROUGHS AND THE ERADICATION OF THE DISEASE. CURRENT COLLABORATIVE PROJECTS INCLUDE THE BIOME OF THE BREAST, MAPPING THE ANATOMY OF THE BREAST DUCTS, MAPPING DCIS, AND LOW COST AUTOMATED ULTRASOUND FOR BREAST CANCER DETECTION AND DIAGNOSIS. 208974 EDUCATION AND OUTREACH PROGRAMDR. SUSAN LOVE RESEARCH FOUNDATION TRANSLATES COMPLEX CONCEPTS REGARDING THE SCIENCE OF BREAST CANCER INTO EASY TO UNDERSTAND INFORMATION IN ORDER TO INFORM, ENGAGE AND EMPOWER PATIENTS, CAREGIVERS AND THE PUBLIC AT LARGE. THROUGH ONLINE AND INTERACTIVE EDUCATIONAL RESOURCES AND MATERIALS, THE FOUNDATION HEIGHTENS UNDERSTANDING OF THE LATEST ADVANCES IN BREAST CANCER CAUSE, DETECTION, PREVENTION AND TREATMENT AND FOSTERS PARTICIPATION IN URGENTLY NEEDED RESEARCH AND ADVOCACY. DR. SUSAN LOVE RESEARCH FOUNDATION DOES THIS THROUGH THE ARMY OF WOMEN PROGRAM (TO DATE MORE THAN 380,000 WOMEN AND MEN HAVE REGISTERED), HEALTH OF WOMEN STUDY, IMPATIENT SCIENCE PROGRAM AND INSPIRING NOVEL RESEARCH BY ORGANIZING BIENNIAL SYMPOSIUMS ON THE INTRADUCTAL APPROACH TO BREAST CANCER AND AWARDING PILOT GRANTS TOTALING MORE THAN $1,000,000. 2272183 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 20 0 1 17 1 0 0 0 0 0 0 0 0 X 8 7 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X X X STEVE GINNEGAR 3108280060 16133 VENTURA BLVD SUITE 1000 ENCINO CA 91436 WILLIAM GREENE DIRECTOR 5.00 X 0 0 0 MELISSA WAYNE DIRECTOR 5.00 X 0 0 0 KATE MCLEAN TREASURER 5.00 X 0 0 0 SONYA ROSENFELD DIRECTOR 5.00 X 0 0 0 HELENE BROWN DIRECTOR 5.00 X 0 0 0 SUSAN LOVE MD PRESIDENT/CHIEF VISIONARY 40.00 X 210000 0 1646 MERIBETH BRAND CHAIRWOMAN 5.00 X 0 0 0 NATALIE T HAGAN SECRETARY 5.00 X 0 0 0 DR KAREN DUVALL VICE CHAIR 5.00 X 0 0 0 HEATHER ORTNER CEO 40.00 X 149015 0 25058 STEPHEN GINNEGAR CFO 40.00 X 106801 0 37626 465816 0 64330 3 0 1 0 CLEARVIEW DIAGNOSTICS INC 57 GEIGAR LANE WARREN NJ 07059 RESEARCH 244999 STAUFFER 2521 WESTWOOD BLVD LOS ANGELES CA 90064 WEBSITE & MAINTENANCE 178000 CI PARTNERS DIRECT INC 1601 EASTMAN AVENUE SUITE 202 VENTURA CA 93003 DIRECT MAIL 103253 3 163793 579877 2223512 2967182 PROGRAM FEES 900099 51500 51500 51500 123239 123239 300000 3240 293035 272262 6965 -269022 -262057 -262057 0 163793 29823 -29823 -29823 312 0 312 312 OTHER INCOME 900099 10 10 10 2850363 51510 0 -168329 X 465816 424835 21558 19423 758651 609345 40367 108939 58655 49540 2966 6149 93655 79101 4736 9818 34403 7120 24531 2752 7350 5602 1748 13000 8845 2125 2030 533008 475976 57032 50109 15277 23110 11722 30621 25862 1549 3210 224604 139540 59675 25389 54278 45214 2338 6726 8306 3092 3843 1371 147485 145485 1000 1000 43218 25315 17903 WEBSITE CONTENT AND MAI 185277 179908 5369 MARKETING/COMMUNICATION 33822 25328 3045 5449 PRINTING AND POSTAGE 12225 501 6852 4872 DUES AND SUBSCRIPTIONS 8911 6297 275 2339 2763394 2272183 217621 273590 143826 610810 55000 130591 27697 68078 623529 380910 419201 242619 2423971 2240065 32363 18186 3102058 3310349 168272 302986 43000 17500 26156 211272 346642 X 2890786 2134109 829598 2890786 2963707 3102058 3310349 86969 -14048 0 X 0 1 X 1 0 X 1938402 1499923 1107457 1717308 2854889 9117979 1938402 1499923 1107457 1717308 2854889 9117979 1706179 7411800 86303 155247 210289 145086 123239 720164 9838143 970595 0.75340 0.74240 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 12159 1621 10538 31555 21497 10058 579815 357792 222023 242619 MUTUAL FUNDS 2088834 F MONEY MARKET FUND 151231 F 2240065 2836315 -14048 -14048 2850363 0 2850363 2763394 0 2763394 0 2763394 LOVE WALK 163793 163793 29823 163793 163793 29823 29823 -29823 1 X X 0 0 0 0 0 0 0 0 0 SUSAN LOVE MD PRESIDENT/CHIEF VISIONARY 210000 0 0 0 0 0 0 0 1646 0 211646 0 0 0 HEATHER ORTNER CEO 149015 0 0 0 0 0 16727 0 8331 0 174073 0 0 0 FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 WILL BE SENT OUT TO THE AUDIT COMMITTEE FOR REVIEW, COMMENT AND APPROVAL BEFORE THE PRESIDENT SIGNS THE RETURN FOR FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS SIGNED ANNUALLY. AT VARIOUS BOARD MEETINGS DURING THE YEAR, THIS IS MONITORED BY ASKING WHETHER THERE ARE ANY NEW CONFLICTS TO ADD TO THE CONFLICT OF INTEREST FORM THAT WAS SIGNED EARLIER. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD REVIEWS THE SALARY OF THE CEO AND OTHER KEY EMPLOYEES TO DETERMINE SALARY. THEY LOOK AT OTHERS THAT ARE IN THE FIELD AND ALSO CONFIRM THAT THE AMOUNT PAID WILL FIT INTO THE ORGANIZATION BUDGET. THIS IS DOCUMENTED AND APPROVED BY THE BOARD BEFORE IT'S DISCUSSED WITH THE EMPLOYEE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, FINANCIAL STATEMENTS AND TAX RETURN AVAILABLE TO THE PUBLIC AT THEIR OFFICES DURING NORMAL BUSINESS HOURS. FORM 990, PART IX, LINE 11G RESEARCH: PROGRAM SERVICE EXPENSES 428,818. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 428,818. DIRECT MAIL: PROGRAM SERVICE EXPENSES 47,158. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 57,032. TOTAL EXPENSES 104,190.